Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 3, 2013, Pages 543-550

  Qin, Baodong ^a   Huang, Fenglou ^a,b   Liang, Yan ^a   Yang, Zaixing ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Hangzhou Sanatorium   (China)

Author keywords

GO analysis; microRNA; Pathway analysis; Primary biliary cirrhosis

Indexed keywords

CALCIUM; MICRORNA; MICRORNA 101; MICRORNA 20A; MICRORNA 22; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84874372441     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12040     Document Type: Article

References (30)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N. Engl. J. Med. 2005; 353: 1261-1273.
2. Smyk DS, Rigopoulou EI, Pares A etal. Sex differences associated with primary biliary cirrhosis. Clin. Dev. Immunol. 2012; 2012: 610504.
3. Selmi C, Mayo MJ, Bach N etal. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485-492.
4. Qin B, Liang Y, Yang Z, Zhong R. Scientific publications on primary biliary cirrhosis from 2000 through 2010: an 11-year survey of the literature. PLoS ONE 2012; 7: e35366.
5. miRBase, the microRNA database. 2012. Cited 3 Jul 2012. Available from URL: http://www.mirbase.org/
6. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
7. Bushati N, Cohen SM. microRNA functions. Annu. Rev. Cell Dev. Biol. 2007; 23: 175-205.
8. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009; 32: 189-194.
9. Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin. Immunol. 2010; 136: 1-15.
10. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J. Lab. Clin. Med. 2006; 147: 126-132.
11. Padgett KA, Lan RY, Leung PC etal. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J. Autoimmun. 2009; 32: 246-253.
12. Lindor KD, Gershwin ME, Poupon R etal. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
14. Ashburner M, Ball CA, Blake JA etal. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000; 25: 25-29.
15. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 2006; 7: 30.
16. Draghici S, Khatri P, Tarca AL etal. A systems biology approach for pathway level analysis. Genome Res. 2007; 17: 1537-1545.
17. Shalgi R, Lieber D, Oren M, Pilpel Y. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput. Biol. 2007; 3: e131.
18. Wright GW, Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003; 19: 2448-2455.
19. Hirschfield GM, Siminovitch KA. Toward the molecular dissection of primary biliary cirrhosis. Hepatology 2009; 50: 1347-1350.
20. Lesma E, Grande V, Di Giulio AM etal. G protein-mediated signal transduction is affected in primary biliary cirrhosis. Hepatol. Res. 2006; 35: 45-52.
21. Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am. J. Physiol. 1997; 273: G602-611.
22. Lleo A, Selmi C, Invernizzi P etal. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009; 49: 871-879.
23. Popov Y, Sverdlov DY, Bhaskar KR etal. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2010; 298: G323-334.
24. Yokoyama T, Komori A, Nakamura M etal. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int. 2006; 26: 467-476.
25. Mishra B, Tang Y, Katuri V etal. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis. Liver Int. 2004; 24: 637-645.
26. Moritoki Y, Lian ZX, Wulff H etal. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 2007; 45: 314-322.
27. Banales JM, Saez E, Uriz M etal. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012; 56: 687-697.
28. Keller A, Leidinger P, Lange J etal. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE 2009; 4: e7440.
29. Zhang Q, Pu R, Du Y etal. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets. Cancer Lett. 2012; 321: 1-12.
30. Osman A. MicroRNAs in health and disease-basic science and clinical applications. Clin. Lab. 2012; 58: 393-402.